Report error Found 864 Enz. Inhib. hit(s) with Target = 'Histone-lysine N-methyltransferase EZH2 [Y641F]'
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.300nMAssay Description:The activity of EZH2 enzyme (with A677G mutant or Y641F mutant) was tested by the following method.The method was used to determine the inhibitory ef...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.300nMAssay Description:The activity of EZH2 enzyme (with A677G mutant or Y641F mutant) was tested by the following method.The method was used to determine the inhibitory ef...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.5nMAssay Description:Table 4: ProceduresCompounds at different concentrations were dissolved in 100% DMSO and transferred to test plates, and the final concentration of D...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.510nMAssay Description:Table 4: ProceduresCompounds at different concentrations were dissolved in 100% DMSO and transferred to test plates, and the final concentration of D...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.510nMAssay Description:Table 4: ProceduresCompounds at different concentrations were dissolved in 100% DMSO and transferred to test plates, and the final concentration of D...More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.520nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.520nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Affinity DataIC50: 0.520nMT: 2°CAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent
Shanghai Synergy Pharmaceutical Sciences Co.
US Patent













































